
    
      Primary Objectives

      Â· To provide genomic profiling for BRCA1 and BRCA2 mutational status in patients' with high
      grade serous ovarian cancer.

      Secondary Objectives

        -  To track the number of women with high grade serous ovarian cancer who are being
           screened in Princess Margaret Cancer Center for mutations in BRCA1/2

        -  To track accrual rates and clinical outcomes in patients with high grade serous ovarian
           cancer who are BRCA1/2-positive

        -  To correlate impact of BRCA1/2 mutational status on clinical outcome

        -  To track utilization of genetic counseling services at Princess Margaret Cancer Centre
    
  